About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 2

Semaglutide for Alcohol Use Disorder

Human Laboratory Screening of Semaglutide for Alcohol Use Disorder

NCT05520775•University of North Carolina, Chapel Hill

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Alcohol Use DisorderCigarette Smoking

Interventions

Semaglutide

Sham/placebo

Locations

1

United States

Locations (1)

UNC-Chapel Hill

Chapel Hill, North Carolina, United States

Key Dates

Start Date

September 2, 2022

Primary Completion Date

April 12, 2024

Completion Date

April 19, 2024

Last Updated

April 2, 2025

Related Studies

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

NCT05855668

Alcohol Use DisorderCannabis Use Disorder

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

NCT06372899

E-cigarette UseCigarette Smoking+2 more

The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers

NCT06264154

SmokingTobacco Use+2 more

Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder

NCT07071779

Alcohol Use Disorder (AUD)Cocaine Use Disorder (CUD)+1 more

Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD)

NCT07413458

Alcohol Use Disorder

RECRUITINGPhase 2

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

NCT06939088

Alcohol Use DisorderAlcohol Abuse/Dependence+6 more

View all related studies

Sponsors

Lead Sponsor

University of North Carolina, Chapel Hill

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 2, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions